A detailed history of Bell Bank transactions in Exact Sciences Corp stock. As of the latest transaction made, Bell Bank holds 5,970 shares of EXAS stock, worth $367,632. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,970
Previous 5,970 -0.0%
Holding current value
$367,632
Previous $252,000 61.11%
% of portfolio
0.05%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023

SELL
$30.35 - $53.15 $11,259 - $19,718
-371 Reduced 5.85%
5,970 $295,000
Q2 2022

Jul 15, 2022

BUY
$35.61 - $76.23 $13,211 - $28,281
371 Added 6.21%
6,341 $250,000
Q2 2020

Aug 13, 2020

SELL
$55.75 - $92.75 $278,750 - $463,750
-5,000 Reduced 45.58%
5,970 $519,000
Q1 2018

May 14, 2018

BUY
$39.82 - $57.53 $237,725 - $343,454
5,970 Added 119.4%
10,970 $442,000
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $232,450 - $302,550
5,000
5,000 $263,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Bell Bank Portfolio

Follow Bell Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Bank, based on Form 13F filings with the SEC.

News

Stay updated on Bell Bank with notifications on news.